Aarkstore Enterprise---angiodynamics, Inc. (ango) - Financial And Strategic Analysis Review

Share:    

AngioDynamics, Inc. (AngioDynamics), a public medical device company, is engaged in designing, developing, manufacturing and marketing therapeutic and diagnostic devices for the treatment of peripheral vascular disease (PVD) and other non-coronary diseases. It focuses on the development of innovative, minimally invasive, image-guided procedures to treat PVD and oncology therapy options including radiofrequency ablation, systems, irreversible electroporation, surgical resection systems and embolization products for the treatment of cancer. The company offers its products to interventional physicians, interventional radiologists, vascular surgeons and others.

AngioDynamics, Inc. Key Recent Developments

Jul 15, 2010 AngioDynamics Reports Net Income Of $12.31 Million In Fiscal 2010

May 20, 2010 AngioDynamics Appoints Lynda Wallace As SVP, Business Development

Apr 20, 2010 AngioDynamics Treats First Patient In IRE Technology Pilot Study

Mar 31, 2010 AngioDynamics Reports Net Income Of $3.3 Million In Q3 Fiscal 2010

Mar 01, 2010 AngioDynamics To Move 65 Employees To New Headquarters In New York

This comprehensive SWOT profile of AngioDynamics, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

For more information please contact :

http://www.aarkstore.com/reports/AngioDynamics-Inc-ANGO-Financial-and-Strategic-Analysis-Review-62731.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by: Aarkstore Enterprise

POST COMMENT

Aarkstore Enterprise---daxor Corporation (dxr) - Financial And Strategic Analysis Review Aarkstore Enterprise---icad, Inc. (icad) - Financial And Strategic Analysis Review Aarkstore Enterprise---cryolife, Inc. (cry) - Financial And Strategic Analysis Review Aarkstore Enterprise---immucell Corporation (iccc) - Financial And Strategic Analysis Review Aarkstore Enterprise---abaxis, Inc. (abax) - Financial And Strategic Analysis Review Aarkstore Enterprise---masimo Corporation (masi) - Financial And Strategic Analysis Review Aarkstore Enterprise---adm Tronics Unlimited, Inc. (admt) - Financial And Strategic Analysis Review Aarkstore Enterprise---diversa Limited (dva) - Financial And Strategic Analysis Review Aarkstore Enterprise---volcano Corporation (volc) - Financial And Strategic Analysis Review Aarkstore Enterprise---helix Biopharma Corp. (hbp) - Financial And Strategic Analysis Review Aarkstore Enterprise---optos Plc (opts) - Financial And Strategic Analysis Review Aarkstore Enterprise---aerocrine Ab (aero B) - Financial And Strategic Analysis Review Aarkstore Enterprise---ablynx (ablx) - Financial And Strategic Analysis Review